Home > Income Statement > WANBURY

WANBURY
Revenue

    Back to Income Statement
WANBURY is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹600 Cr₹578 Cr₹500 Cr₹511 Cr₹393 Cr

What is the latest Revenue of WANBURY ?

The latest Revenue ratio of WANBURY is ₹600 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹600 Cr
Mar2024₹578 Cr
Mar2023₹500 Cr
Mar2022₹511 Cr
Mar2021₹393 Cr

How is Revenue of WANBURY Trending?

Years Revenue % Change
Mar2025 ₹600 Cr
3.77
Mar2024 ₹578 Cr
15.63
Mar2023 ₹500 Cr
-2.26
Mar2022 ₹511 Cr
30.23
Mar2021 ₹393 Cr -

Compare Revenue of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹1,036.9 Cr 4.5% 14.6% 1.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,331.0 Cr 1.2% 8.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹181,466.0 Cr -0.2% 3% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,952.0 Cr 1.7% 9.9% 46.8% Stock Analytics
CIPLA ₹116,229.0 Cr -2.2% 4.5% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,959.0 Cr -9% -2.1% -1.8% Stock Analytics


WANBURY Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

4.5%

14.6%

1.7%

SENSEX

-0.3%

4.9%

-7%


You may also like the below Video Courses